Athanor Capital’s Edwards Lifesciences EW Stock Holding History

Athanor Capital’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-20,851	Closed	-$1.66M	–	730
2020 Q3	$1.66M	Buy	+20,851	New	+$1.63M	0.06%	166

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Athanor Capital's EW Position: Q4 2020 in Review

Athanor Capital sold out of Edwards Lifesciences (EW) in Q4 2020, closing a stake of 20,851 shares — an estimated $1.66M sold.

Athanor Capital first reported a position in EW in Q3 2020 and held it in 1 quarter. The position peaked at $1.66M in Q3 2020. 1,158 funds tracked by Wall St. Rank hold EW as of Q4 2020.

Athanor Capital reported no remaining Edwards Lifesciences position as of Q4 2020 after selling out during the quarter.
Athanor Capital sold 20,851 Edwards Lifesciences shares in Q4 2020, an estimated $1.66M.
Athanor Capital first reported a position in Edwards Lifesciences in Q3 2020 and held it in 1 quarter.
Athanor Capital's Edwards Lifesciences position peaked at $1.66M in Q3 2020.
1,158 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2020.

Based on Athanor Capital's 13F filing for Q4 2020, filed 16 Feb 2021.